NumerixS Investment Technologies’s Heron Therapeutics HRTX Stock Holding History

NumerixS Investment Technologies’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,101	Closed	-$60K	–	1170
2020 Q1	$60K	Buy	5,101 +4,801	+1,600%	+$90.2K	0.03%	572
2019 Q4	$7K	Buy	+300	New	+$6.64K	﹤0.01%	999
2018 Q4	–	Sell	-1,900	Closed	-$60K	–	1210
2018 Q3	$60K	Buy	+1,900	New	+$70.8K	0.01%	931
2017 Q1	–	Sell	-11,800	Closed	-$155K	–	1246
2016 Q4	$155K	Buy	+11,800	New	+$185K	0.02%	754

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NumerixS Investment Technologies's HRTX Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Heron Therapeutics (HRTX) in Q2 2020, closing a stake of 5,101 shares — an estimated $60K sold.

NumerixS Investment Technologies first reported a position in HRTX in Q4 2016 and held it in 4 quarters. The position peaked at $155K in Q4 2016. 190 funds tracked by Wall St. Rank hold HRTX as of Q2 2020.

NumerixS Investment Technologies reported no remaining Heron Therapeutics position as of Q2 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 5,101 Heron Therapeutics shares in Q2 2020, an estimated $60K.
NumerixS Investment Technologies first reported a position in Heron Therapeutics in Q4 2016 and held it in 4 quarters.
NumerixS Investment Technologies's Heron Therapeutics position peaked at $155K in Q4 2016.
190 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.